Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96

Clinical trial NCT02133079 · UNKNOWN

Trial details

NCT number: NCT02133079
Sponsor: Cure&Sure Biotech Co., LTD
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Liver Cancer Pancreatic Adenocarcinoma

Start date: 2012-03-01
Primary completion: 2016-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.